Condition: Chronic Kidney Disease Stage 3B · Chronic Kidney Disease stage4 · Chronic Kidney Disease Stage 5 · Sponsor: Dr. Schär AG / SPA
The KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day is recommended. FLAVIS® is a product line of hypoprotein foods specially developed for the treatment of CKD.The use of low-protein foods may facilitate the achievement of nutritional goals in terms of protein intake and help patients to follow a low-protein diet.
This description comes directly from the study's public registry record.
Vinciane Dumay · 0756917356 · v.dumay@slbpharma.com
Ophélie Flageul · 0299121962 · o.flageul@slbpharma.com
Always discuss trial participation with your own doctor first.
| Clinique sainte isabelle | Abbeville, France | Recruiting |
| Cabinet médical du Dr Magnant | Aix-en-Provence, France | Completed |
| CHU Besançon | Besançon, France | Recruiting |
| Maison du Rein | Bordeaux, France | Recruiting |
| Polyclinique Bordeaux Nord Aquitaine | Bordeaux, France | Recruiting |
| CH Chalon | Chalon-sur-Saône, France | Recruiting |
| CHU Gabriel Montpied | Clermont-Ferrand, France | Recruiting |
| Santélys BFC | Dijon, France | Withdrawn |
| CH Le Mans | Le Mans, France | Recruiting |
| Hospices Civiles de Lyon | Lyon, France | Recruiting |
| Hôpital Edouard Heriot | Lyon, France | Withdrawn |
| Saint Joseph Saint Luc | Lyon, France | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05489120